share_log

JP Morgan Reinstates Neutral on Deciphera Pharmaceuticals, Announces $14 Price Target

Benzinga ·  Nov 20, 2023 08:17

JP Morgan analyst Jessica Fye reinstates Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Neutral and announces $14 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment